Article Versions Notes

Sharad S, Sztupinszki ZM, Chen Y, Kuo C, Ravindranath L, Szallasi Z, Petrovics G, Sreenath TL, Dobi A, Rosner IL, et al. Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer. Cancers. 2019; 11(12):1995. https://doi.org/10.3390/cancers11121995

Sharad, Shashwat, Zsófia M. Sztupinszki, Yongmei Chen, Claire Kuo, Lakshmi Ravindranath, Zoltan Szallasi, Gyorgy Petrovics, Taduru L. Sreenath, Albert Dobi, Inger L. Rosner, and et al. 2019. "Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer" Cancers 11, no. 12: 1995. https://doi.org/10.3390/cancers11121995

Sharad, S., Sztupinszki, Z. M., Chen, Y., Kuo, C., Ravindranath, L., Szallasi, Z., Petrovics, G., Sreenath, T. L., Dobi, A., Rosner, I. L., Srinivasan, A., Srivastava, S., Cullen, J., & Li, H. (2019). Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer. Cancers, 11(12), 1995. https://doi.org/10.3390/cancers11121995